AR023481A1 - Vectores que contienen un gen que codifica cd40 y/o cd40l bajo el control de un promotor citoquina-inducible, metodos para su produccion y usos de losmismos - Google Patents
Vectores que contienen un gen que codifica cd40 y/o cd40l bajo el control de un promotor citoquina-inducible, metodos para su produccion y usos de losmismosInfo
- Publication number
- AR023481A1 AR023481A1 ARP000101715A AR023481A1 AR 023481 A1 AR023481 A1 AR 023481A1 AR P000101715 A ARP000101715 A AR P000101715A AR 023481 A1 AR023481 A1 AR 023481A1
- Authority
- AR
- Argentina
- Prior art keywords
- control
- inducible promoter
- cytokin
- codifying
- gen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Un vector para la expresion de un ácido nucleico que codifica por lo menos un polipéptido con una actividad de CD40 y/o CD154, en el cual la expresion dedicho ácido nucleico se halla bajo el control de una promotor citoquina-inducible, es preferentemente administrado localmente a los tumores solidos, para laterapia de tumores.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99107611A EP1067194A1 (en) | 1999-04-16 | 1999-04-16 | Vectors containing a gene coding for CD40 and/or CD40L under the control of a cytokine-inducible promoter which is a human acute phase amyloid A gene promoter. Methods for their production and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
AR023481A1 true AR023481A1 (es) | 2002-09-04 |
Family
ID=8237977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000101715 AR023481A1 (es) | 1999-04-16 | 2000-04-13 | Vectores que contienen un gen que codifica cd40 y/o cd40l bajo el control de un promotor citoquina-inducible, metodos para su produccion y usos de losmismos |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1067194A1 (es) |
AR (1) | AR023481A1 (es) |
AU (1) | AU4747400A (es) |
WO (1) | WO2000063405A1 (es) |
ZA (1) | ZA200107160B (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3511023B2 (ja) | 1999-08-25 | 2004-03-29 | アキュプレックス,リミティド ライアビリティーカンパニー | 感染及び炎症状態の検出のための分泌された生物学的流体の診断アッセイ |
CA2387907A1 (en) | 1999-10-22 | 2001-05-03 | The Board Of Regents Of The University Of Nebraska | Serum amyloid a isoform from colostrum |
AUPQ755300A0 (en) | 2000-05-17 | 2000-06-08 | Monash University | Immune potentiating compositions |
US20040071656A1 (en) * | 2001-12-26 | 2004-04-15 | Felix Wieland | Modulation of heat-shock-protein-based immunotherapies |
US7368546B2 (en) | 2003-01-21 | 2008-05-06 | The Board Of Regents Of The University Of Nebraska | Human SAA3 nucleic acid molecule, protein, and methods of use for same |
EP2066339B1 (en) | 2006-09-18 | 2014-08-13 | The Board Of Trustees Of The University Of Arkansas | Compositions and methods of enhancing immune responses |
US9125854B2 (en) | 2007-10-30 | 2015-09-08 | The Board Of Trustees Of The University Of Arkansas | Compositions and methods of enhancing immune responses to flagellated bacterium |
EP3097926B1 (en) | 2007-11-01 | 2019-10-02 | The Board of Trustees of the University of Arkansas | Compositions and methods of enhancing immune responses to eimeria |
JP6242050B2 (ja) | 2010-01-21 | 2017-12-06 | ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ アーカンソー | 免疫応答を増強するワクチンベクターおよび方法 |
KR101881611B1 (ko) | 2010-06-09 | 2018-07-25 | 더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 | 캄필로박터 감염을 감소시키기 위한 백신 및 방법 |
ES2968398T3 (es) | 2013-02-14 | 2024-05-09 | Univ Arkansas | Composiciones y métodos para potenciar las respuestas inmunitarias a Eimeria o limitar la infección por Eimeria |
EP3578190A1 (en) | 2013-03-15 | 2019-12-11 | The Board of Trustees of the University of Arkansas | Compositions and methods of enhancing immune responses to enteric pathogens |
AR108688A1 (es) | 2016-05-03 | 2018-09-19 | Univ Arkansas | Vector de vacuna de levadura que incluye polipéptidos inmunoestimuladores y antigénicos, métodos para su uso |
TW202302625A (zh) * | 2021-03-12 | 2023-01-16 | 美商健生生物科技公司 | 經生物工程改造之免疫調節融合蛋白組成物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2198025T3 (es) * | 1991-10-25 | 2004-01-16 | Immunex Corporation | Anticuerpos contra cd40-l. |
AU5098493A (en) * | 1992-08-21 | 1994-03-15 | Schering Corporation | Cd40 ligand, anti cd40 antibodies, and soluble cd40 |
US5744304A (en) * | 1995-05-30 | 1998-04-28 | Board Of Regents, The University Of Texas System | Inflammation-induced expression of a recombinant gene |
WO1998040506A1 (en) * | 1997-03-08 | 1998-09-17 | Roche Diagnostics Gmbh | Use of an acute phase serum amyloid a gene promoter (a-saa promoter) in the treatment of diseases in mammals |
-
1999
- 1999-04-16 EP EP99107611A patent/EP1067194A1/en not_active Withdrawn
-
2000
- 2000-04-13 AU AU47474/00A patent/AU4747400A/en not_active Abandoned
- 2000-04-13 WO PCT/EP2000/003353 patent/WO2000063405A1/en active Application Filing
- 2000-04-13 AR ARP000101715 patent/AR023481A1/es unknown
-
2001
- 2001-08-29 ZA ZA200107160A patent/ZA200107160B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU4747400A (en) | 2000-11-02 |
WO2000063405A1 (en) | 2000-10-26 |
EP1067194A1 (en) | 2001-01-10 |
ZA200107160B (en) | 2002-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR023481A1 (es) | Vectores que contienen un gen que codifica cd40 y/o cd40l bajo el control de un promotor citoquina-inducible, metodos para su produccion y usos de losmismos | |
ATE414775T1 (de) | Polypeptide mit prolyldipeptidylaminopeptidase- aktivität und dafür kodierende nukleinsäuren | |
ATE352626T1 (de) | Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren | |
ES8702432A1 (es) | Procedimiento para la purificacion de una proteina | |
ATE319818T1 (de) | Polypeptide mit aminopeptidaseaktivität und für diese kodierende nukleinsäuren | |
AR077576A2 (es) | Un peptido de telomerasa y composiciones farmaceuticas para el tratamiento contra el cancer que comprenden tales peptidos | |
NO953699D0 (no) | Isolerte nukleinsyremolekyler som koder for tumor-rejeksjonsforlöperen MAGE-3, samt anvendelser derav | |
AR023482A1 (es) | Acidos nucleicos que codifican polipeptidos quimericos cd40/cd4ol, metodos para su produccion y usos de los mismos | |
ES2087155T3 (es) | Peptidos sinteticos para su utilizacion en la deteccion in vivo de trombos. | |
CO4850588A1 (es) | Compuestos para inmunoterapia del cancer de prostata . | |
ES2137182T3 (es) | Derivados recombinantes del factor viii humano. | |
DE69930955D1 (de) | Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren | |
UY23561A1 (es) | Procedimiento para la preparacion de tnf-muteinas | |
HK1010785A1 (en) | Therapeutic peptides | |
CY1108459T1 (el) | Ακτ-3 νουκλεϊκα οξεα, πολυπεπτιδια, και χρησεις αυτων | |
MX9306220A (es) | Ptp 1d: una proteina tirosina fosfatasa novedosa. | |
CL2019003405A1 (es) | Péptido asociados a tumor (tumap) aislado; ácido nucleico; vector de expresión; célula huésped recombinante que comprendes el péptido; método para producir el péptido; uso para preparar un medicamento útil rara tratar el cáncer; kit farmacéutico. (divisional solicitud 201702407) | |
DE69837475D1 (de) | Polypeptide mit aminopeptidaseaktivität und dafür kodierende nukleinsäuren | |
ATE384787T1 (de) | Tripeptidyl-aminopeptidase | |
CO5640064A2 (es) | Citomodilacion de peptidos para tratar cistitis intersticial | |
AR013618A1 (es) | Metodo y composiciones para la distribucion y expresion de acidos nucleicos de interferon | |
AR241800A1 (es) | Procedimiento para preparar compuestos de eglina y procedimiento para obtener preparados farmaceuticos que incluyan a dichos compuestos de eglina como agente activo. | |
ES2182501T3 (es) | Metodos mejorados para producir proteinas del factor viii. | |
AR010924A1 (es) | Azapeptidos ciclicos, sus enantiomeros y diastereomeros, un procedimiento para su preparacion, su empleo para preparar un medicamento, las preparacionesfarmaceuticas que los contienen y un procedimiento para obtener estas preparaciones farmaceuticas. | |
Cawley et al. | Nucleotide sequence of cDNA encoding the catalytic subunit of phosphorylase kinase from rat soleus muscle. |